Pfizer's and Moderna's formulas have been the go-to on pharmacy shelves, but Novavax remains an important option.

Now, let's get back to our question. Is the stock a buy or a sell? This depends a lot on your own particular investment ...

NACI added that anyone above 6 months of age who isn't considered high risk "may receive the most recently updated vaccine in ...

Moderna stock is plunging Thursday after the COVID-19 vaccine maker announced plans to drastically cut its R&D spending to focus on new product approvals.

Moderna aims to reduce its research and development budget by about 20 percent over the next three years as the biotech tries to find a path to profitability following disappointing vaccine sales.

It uses manufactured Covid-19 virus proteins (unlike Pfizer, Moderna and Astra ... Peterson says powdered vaccines could stop people having to carry cool boxes "on bicycles and camels" But there ...

SPIKEVAX® is the first updated COVID-19 vaccine authorized in Canada for 2024-2025, offering a timely solution to help protect Canadians ...

Moderna plans to cut $1.1bn in costs by 2027, pausing and scrapping several R&D programs. See why I think further downside ...

Health officials warn that the new COVID variant XEC, rapidly spreading in Europe, could become the predominant strain in the ...

Still, both Pfizer and Moderna have said that their new vaccines can produce stronger ... everything you need is in the box.

Shares of Moderna tumbled early Thursday after the vaccine developer said it was cutting research and development spending and pushed back its time frame for breaking even. The company also forecast a ...

Stocks opened and closed in positive territory, though the path to the finish line was choppy. A mixed reading on wholesale ...